Annual Cash & Cash Equivalents
$10.16B$2.74B-21.21%
Summary
- Current Value
- As of today, BNTX annual cash & cash equivalents is $10.16B, down -21.21% on
- Historical Performance
- BNTX annual cash & cash equivalents is up +430.02% over the past 3 years, and up +1646.75% over the past 5 years
- All-Time High Comparison
- BNTX annual cash & cash equivalents is currently -31.73% below its historical high of $14.88B set on
- 3-Year Low Comparison
- BNTX annual cash & cash equivalents is at its 3-year low
- Sector Comparison
- BNTX annual cash & cash equivalents is higher than 99.15% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $10.16B | -21.2% | +430.0% | +1646.8% | +3064.1% | |
| Quarterly Cash & Cash Equivalents | $16.89B | -9.4% | +28.5% | +1354.5% | – | |
| Price | $107.19 | -4.7% | -26.1% | +1.3% | – | |
| Annual Current Assets | $19.57B | -9.3% | +14.7% | +3018.3% | +5718.0% | |
| Annual Total Liabilities | $3.23B | +5.9% | -27.9% | +845.9% | +753.0% | |
| Annual Working Capital | $16.86B | -12.6% | +28.4% | +3508.9% | +5998.4% | |
| Annual Net Income | -$719.65M | -171.6% | -105.9% | -258.9% | – |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $14.88B | N/A | -31.7% |
| 5Y | $14.88B | -31.7% | |
| All | $14.88B | -31.7% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $10.16B | at low | |
| 5Y | $1.49B | N/A | +582.4% |
| All | $206.48M | +4819.7% |
Cash and Cash Equivalents History
| Year | Value | Change |
|---|---|---|
| $10.16B | -21.2% | |
| $12.89B | -13.4% | |
| $14.88B | +676.4% | |
| $1.92B | +28.8% | |
| $1.49B | +156.0% |
| Year | Value | Change |
|---|---|---|
| $581.54M | +23.5% | |
| $470.71M | +128.0% | |
| $206.48M | -35.7% | |
| $321.04M | - |
FAQ
What is the current annual cash & cash equivalents of BNTX?
As of today, BNTX annual cash & cash equivalents is $10.16B
What is 1-year change in BNTX annual cash & cash equivalents?
BNTX annual cash & cash equivalents is down -21.21% year-over-year
What is 3-year change in BNTX annual cash & cash equivalents?
BNTX annual cash & cash equivalents is up +430.02% over the past 3 years
How far is BNTX annual cash & cash equivalents from its all-time high?
BNTX annual cash & cash equivalents is currently -31.73% below its historical high of $14.88B set on December 31, 2022
How does BNTX annual cash & cash equivalents rank versus sector peers?
BNTX annual cash & cash equivalents is higher than 99.15% of companies in Healthcare sector
When is BNTX next annual earnings release?
The next annual earnings release for BNTX is on
Quarterly Cash & Cash Equivalents
$16.89B$861.47M+5.37%
Summary
- Current Value
- As of today, BNTX quarterly cash & cash equivalents is $16.89B, up +5.37% on
- Historical Performance
- BNTX quarterly cash & cash equivalents is down -9.41% year-over-year, and up +28.46% over the past 3 years
- All-Time High Comparison
- BNTX quarterly cash & cash equivalents is currently -9.41% below its historical high of $18.65B set on
- 3-Year Low Comparison
- BNTX quarterly cash & cash equivalents is +74.26% above its 3-year low of $9.69B reached on
- Sector Comparison
- BNTX quarterly cash & cash equivalents is higher than 99.66% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $16.89B | +5.4% | -9.4% | +28.5% | +1354.5% | |
| Annual Cash & Cash Equivalents | $10.16B | – | -21.2% | +430.0% | +1646.8% | |
| Price | $107.19 | +4.5% | -4.7% | -26.1% | +1.3% | |
| Quarterly Current Assets | $18.60B | -0.5% | -9.8% | -10.4% | +1365.1% | |
| Quarterly Total Liabilities | $3.36B | -8.5% | -8.3% | -20.0% | +450.2% | |
| Quarterly Working Capital | $15.99B | -3.2% | -10.3% | -5.3% | +1574.6% | |
| Quarterly Net Income | -$33.54M | +92.3% | -115.4% | -101.9% | +86.3% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $16.89B | at high | |
| 3Y | $18.65B | -9.4% | |
| 5Y | $18.65B | -9.4% | |
| All | $18.65B | -9.4% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $14.84B | +13.8% | |
| 3Y | $9.69B | +74.3% | |
| 5Y | $1.05B | +1512.3% | |
| All | $323.92M | +5115.4% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of BNTX?
As of today, BNTX quarterly cash & cash equivalents is $16.89B
What is BNTX quarterly cash & cash equivalents most recent change?
BNTX quarterly cash & cash equivalents was up +5.37% on September 30, 2025
What is 1-year change in BNTX quarterly cash & cash equivalents?
BNTX quarterly cash & cash equivalents is down -9.41% year-over-year
How far is BNTX quarterly cash & cash equivalents from its all-time high?
BNTX quarterly cash & cash equivalents is currently -9.41% below its historical high of $18.65B set on September 30, 2024
How does BNTX quarterly cash & cash equivalents rank versus sector peers?
BNTX quarterly cash & cash equivalents is higher than 99.66% of companies in Healthcare sector
When is BNTX next earnings release?
The next earnings release for BNTX is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- BNTX Official Website www.biontech.de
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1776985/000177698525000065/0001776985-25-000065-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1776985/000177698525000013/0001776985-25-000013-index.htm
- BNTX Profile on Yahoo Finance finance.yahoo.com/quote/BNTX
- BNTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bntx